US Patent 10369193 Gene therapy for neurodegenerative disorders
Patent 10369193 was granted and assigned to Genzyme on August, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 20, 2016
Date of Patent
August 6, 2019
Patent Applicant
Patent Application Number
15160949
Patent Citations Received
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10369193 Gene therapy for neurodegenerative disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.